Accellent Announces Early Tender Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WILMINGTON, Mass.--(BUSINESS WIRE)--Accellent Inc. (“Accellent” or the “Company”) announced today that, in connection with the previously announced cash tender offers for (i) any and all of the $400,000,000 aggregate principal amount of its outstanding 8 3/8% Senior Secured Notes due 2017 (the “Senior Secured Notes”) (the “Senior Secured Notes Offer”) and (ii) any and all of the $315,000,000 aggregate principal amount of its outstanding 10% Senior Subordinated Notes due 2017 (the “Senior Subordinated Notes” and, together with the Senior Secured Notes, the “Notes” and, individually, a “series” of Notes) (the “Senior Subordinated Notes Offer”), holders of $368,651,000 of the Senior Secured Notes, or 92.16% of the outstanding principal amount, and holders of $244,622,000 of the Senior Subordinated Notes, or 77.66% of the outstanding principal amount, tendered their notes in the Senior Secured Notes Offer and the Senior Subordinated Notes Offer on or prior to 5:00 p.m., New York City time, on February 25, 2014 (with respect to each Offer (as defined below) the “Early Tender Date”). The Senior Secured Notes Offer and the Senior Subordinated Notes Offer are collectively referred to as the “Offers” and with respect to each series of Notes, each individually as an “Offer.”

Help employers find you! Check out all the jobs and post your resume.

Back to news